TUCUXI-Reference-Cited by-同舟云学术

TUCUXI

Published:2017-08-20 Issue: Volume: Page:
ISSN:
Container-title:Proceedings of the 8th ACM International Conference on Bioinformatics, Computational Biology,and Health Informatics
language:
Short-container-title:

Author:

Dubovitskaya Alevtina¹,Buclin Thierry²,Schumacher Michael³,Aberer Karl⁴,Thoma Yann⁵

Affiliation:

1. University of Applied Sciences Western Switzerland & Swiss Federal Institute of Technology, Sierre, Switzerland

2. University Hospital, Lausanne, Lausanne, Switzerland

3. University of Applied Sciences Western Switzerland, Sierre, Switzerland

4. Swiss Federal Institute of Technology, Lausanne, Switzerland

5. HEIG-VD, Yverdon-les-Bains, Switzerland

Funder

SNSF Nano-Tera.ch

Publisher

ACM

Link

https://dl.acm.org/doi/pdf/10.1145/3107411.3107439

Reference10 articles.

1. Basma Al-Metwali and Hussain Mulla 2017. Personalised dosing of medicines for children. Journal of Pharmacy and Pharmacology (2017). Basma Al-Metwali and Hussain Mulla 2017. Personalised dosing of medicines for children. Journal of Pharmacy and Pharmacology (2017).

2. Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals

3. AJ Boeckmann LB Sheiner and SL Beal 1994. NONMEM users guide. San Francisco: University of California San Francisco (1994). AJ Boeckmann LB Sheiner and SL Beal 1994. NONMEM users guide. San Francisco: University of California San Francisco (1994).

4. Olivier Capitain Andreaa Asevoaia Michele Boisdron-Celle Anne-Lise Poirier Alain Morel and Erick Gamelin 2012. Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II proof-of-concept study. Clinical colorectal cancer Vol. 11 4 (2012) 263--267. Olivier Capitain Andreaa Asevoaia Michele Boisdron-Celle Anne-Lise Poirier Alain Morel and Erick Gamelin 2012. Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II proof-of-concept study. Clinical colorectal cancer Vol. 11 4 (2012) 263--267.

5. Giulia Cappi Fabio M Spiga Yessica Moncada Anna Ferretti Michael Beyeler Marco Bianchessi Laurent Decosterd Thierry Buclin and Carlotta Guiducci 2015. Label-free detection of tobramycin in serum by transmission-localized surface plasmon resonance. Analytical chemistry Vol. 87 10 (2015) 5278--5285. Giulia Cappi Fabio M Spiga Yessica Moncada Anna Ferretti Michael Beyeler Marco Bianchessi Laurent Decosterd Thierry Buclin and Carlotta Guiducci 2015. Label-free detection of tobramycin in serum by transmission-localized surface plasmon resonance. Analytical chemistry Vol. 87 10 (2015) 5278--5285.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates;Clinical Pharmacokinetics;2024-02-28

2. The TuberXpert project protocol: Towards a Clinical Decision Support System for therapeutic anti-tuberculosis medical drugs monitoring in Tanzania;2023-12-24

3. Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT;Transplantation and Cellular Therapy;2023-12

4. AUC-based monitoring and model-informed precision dosing of vancomycin in critically ill patients: why and how?;Anaesthesia Critical Care & Pain Medicine;2023-12

5. Pharmacokinetic Consideration of Venetoclax in Acute Myeloid Leukemia Patients: A Potential Candidate for TDM? A Short Communication;Therapeutic Drug Monitoring;2023-11-08